- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01483391
Early Intervention for Youth at Risk for Bipolar Disorder
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Children who are at high risk for developing bipolar disorder (BD) often are showing significant mood swings or depression well before they develop the full disorder. Often, these children have one or more parents who have bipolar disorder. In addition to brief episodes of lethargic depression and mania or hypomania (periods of excessive activity), children and adolescents at risk for BD often have co-occurring disorders, such as attention deficit hyperactivity disorder, conduct disorder, substance abuse disorders, and anxiety disorders.
Early interventions may lead to better mental health by preventing BD from ever fully expressing itself. This study will test an early intervention for BD called family-focused treatment (FFT), which has been designed to help children and adolescents who are at risk for developing BD. FFT will combine education about BD with training in communication strategies and problem-solving skills. It will focus on the family, because family environmental factors are related to the course and recurrence of BD. By reducing risk factors and teaching coping skills, FFT aims to reduce the early symptoms of BD, improve functioning, and delay the onset or reduce the severity of manic episodes.
Participation in this study will last up to 4 years, although the majority of the study will occur in the first year. There are three parts. In the first part, participating children and their families will complete research interviews and questionnaires about the child's mood, behavior, beliefs, and problems. Parent participants will provide information on the family background of mood or anxiety problems. All participants will receive a thorough medical-psychiatric evaluation and be provided with pharmacotherapy (as needed) from a study psychiatrist for the first year of the study.
In the second part, participants will be randomly assigned to receive one of two treatments: FFT or enhanced care. Participants receiving FFT will complete 12 therapy sessions in which parents, children, and siblings learn how to cope with mood disorders, new ways to talk to each other, and strategies for solving family problems. FFT sessions will occur weekly for the first 8 weeks and then every other week for the next 8 weeks. Participants receiving enhanced care will have 3 weekly sessions which will involve the youth and all family members. In session 1, clinicians summarize the diagnostic assessment, introduce mood charting, and offer instructional handouts on managing mood swings. In session 2, clinicians revisit mood charting, discuss medications (if relevant), and help the child and family develop a mood management plan. In session 3, families rehearse mood regulation strategies for current family, social or academic problems. Clinicians then meet with the child individually every month for the next 3 mos. to provide support, assist with problem-solving, and troubleshoot use of the mood management plan. So, both treatments last 4 months.
In the third part of the study, participants will complete follow-up assessments every 4 months for 1 year. Assessments will include interviews and questionnaires similar to those completed in the first part of the study.
The statistical analyses for this study will examine changes in symptoms and functioning from the baseline assessment through the 4 month follow-ups in year 1 and the 6 month follow-ups in years 2-4.
Typ studie
Zápis (Očekávaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
California
-
Los Angeles, California, Spojené státy, 90024-1759
- UCLA Child and Adolescent Mood Disorders Program, UCLA School of Medicine
-
Stanford, California, Spojené státy, 94304
- Stanford University School of Medicine, Lucile Packard Children's Hospital
-
-
Colorado
-
Boulder, Colorado, Spojené státy, 80309
- University of Colorado, Boulder
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
For a child to be eligible:
- At least one biological parent or stepparent with whom the child or adolescent lives must be willing to participate in family treatment
- At least one biological parent has a verifiable diagnosis of bipolar disorder I or II
- The child must have a DSM-IV diagnosis of bipolar disorder not otherwise specified or major depressive disorder (MDD)
- If the main diagnosis is MDD, the depressive episode must have occurred within the past 2 years
- The child must have evidence of current significant affective symptoms, as determined by a score greater than 11 on the Young Mania Rating Scale within the last week or a score greater than 29 on the Child Depression Rating Scale-Revised within the last 2 weeks
- The family must speak English, although English need not be their first language
Exclusion Criteria:
- Fully diagnosable bipolar disorder I or II
- Diagnosis of autism or pervasive developmental disorder
- Evidence of mental retardation, as defined by an intelligence quotient (IQ) less than 70
- Presence of comorbid neurologic diseases such as seizure disorder
- Substance or alcohol abuse or dependence disorders in the 4 months prior to study recruitment
- Evidence of a life-threatening eating disorder or other medical disorder that requires emergency medical treatment
- Currently enrolled in regular family therapy
- Evidence of current sexual or physical abuse or domestic abuse between the adult partners
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Prevence
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Aktivní komparátor: Enhanced Care
Three sessions of family education and three sessions of individual support over 4 months.
|
The 3 family sessions involve the youth and all family members.
These sessions will help the child and family members with mood charting and developing a mood management plan.
Families will rehearse mood regulation strategies for current family, social or academic problems.
Clinicians then meet with the child individually every month for the next 3 mos.
to provide support, assist with problem-solving, and troubleshoot use of the mood management plan.
Ostatní jména:
|
|
Experimentální: Family-Focused Treatment
12 therapy sessions involving the at-risk child or adolescent, parents, and available siblings.
Therapy will include psychoeducation about mood disorders, communication enhancement training, and problem-solving skills training.
|
12 therapy sessions involving the at-risk child or adolescent, parents, and available siblings.
Therapy will include psychoeducation about mood disorders, communication enhancement training, and problem-solving skills training.
The goal of this intervention is to improve the child's ability to regulate moods and to reduce tension and conflict in the family.
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Changes in symptom severity
Časové okno: Measured at baseline, every 4 months in year 1, and every 6 months in years 2-4
|
Changes in symptoms of at-risk children, as defined by depression and (hypo)mania scores and psychiatric status on the Adolescent Longitudinal Interval Follow-up Evaluation (A-LIFE, the Child Depression Rating Scale, and the Young Mania Rating Scale
|
Measured at baseline, every 4 months in year 1, and every 6 months in years 2-4
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Delaying onset of a first (hypo)manic or mixed episode
Časové okno: 2-4 years
|
We will evaluate through survival analyses whether family-focused treatment, due to its ameliorative effects on acute symptoms, is superior to enhanced care in delaying onset of a first (hypo)manic or mixed episode during the 2-4 year follow-up.
|
2-4 years
|
|
Psychosocial functioning
Časové okno: Measured at baseline, every 4 months in year 1 and every 6 months in years 2-4
|
Youths in family-focused treatment will show greater improvement from pretreatment to end of a 2-4 year follow-up in psychosocial functioning compared to youth in Enhanced Care.
|
Measured at baseline, every 4 months in year 1 and every 6 months in years 2-4
|
|
Mental health service use
Časové okno: Measured at baseline, every 4 months in year 1 and every 6 months in years 2-4
|
Youth in family-focused treatment will require fewer mental health services from pretreatment to end of a 2-4 year follow-up than youth in enhanced care
|
Measured at baseline, every 4 months in year 1 and every 6 months in years 2-4
|
Spolupracovníci a vyšetřovatelé
Vyšetřovatelé
- Vrchní vyšetřovatel: David J Miklowitz, PhD, UCLA Department of Psychiatry
- Vrchní vyšetřovatel: Kiki D Chang, MD, Stanford University
- Vrchní vyšetřovatel: Christopher D Schneck, MD, University of Colorado, Denver
Publikace a užitečné odkazy
Obecné publikace
- Miklowitz DJ, Chang KD. Prevention of bipolar disorder in at-risk children: theoretical assumptions and empirical foundations. Dev Psychopathol. 2008 Summer;20(3):881-97. doi: 10.1017/S0954579408000424.
- Miklowitz DJ, Chang KD, Taylor DO, George EL, Singh MK, Schneck CD, Dickinson LM, Howe ME, Garber J. Early psychosocial intervention for youth at risk for bipolar I or II disorder: a one-year treatment development trial. Bipolar Disord. 2011 Feb;13(1):67-75. doi: 10.1111/j.1399-5618.2011.00890.x.
- Miklowitz DJ, Weintraub MJ, Singh MK, Walshaw PD, Merranko JA, Birmaher B, Chang KD, Schneck CD. Mood Instability in Youth at High Risk for Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2022 Oct;61(10):1285-1295. doi: 10.1016/j.jaac.2022.03.009. Epub 2022 Mar 17.
- Singh MK, Nimarko AF, Garrett AS, Gorelik AJ, Roybal DJ, Walshaw PD, Chang KD, Miklowitz DJ. Changes in Intrinsic Brain Connectivity in Family-Focused Therapy Versus Standard Psychoeducation Among Youths at High Risk for Bipolar Disorder. J Am Acad Child Adolesc Psychiatry. 2021 Apr;60(4):458-469. doi: 10.1016/j.jaac.2020.07.892. Epub 2020 Aug 1.
- Miklowitz DJ, Schneck CD, Walshaw PD, Singh MK, Sullivan AE, Suddath RL, Forgey Borlik M, Sugar CA, Chang KD. Effects of Family-Focused Therapy vs Enhanced Usual Care for Symptomatic Youths at High Risk for Bipolar Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2020 May 1;77(5):455-463. doi: 10.1001/jamapsychiatry.2019.4520.
- Miklowitz DJ, Portnoff LC, Armstrong CC, Keenan-Miller D, Breen EC, Muscatell KA, Eisenberger NI, Irwin MR. Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders. Psychiatry Res. 2016 Jul 30;241:315-22. doi: 10.1016/j.psychres.2016.04.120. Epub 2016 May 7.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- R01MH093676 (Grant/smlouva NIH USA)
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Časový rámec sdílení IPD
Typ podpůrných informací pro sdílení IPD
- Protokol studie
- Plán statistické analýzy (SAP)
- Formulář informovaného souhlasu (ICF)
- Analytický kód
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Enhanced Care
-
Xuanwu Hospital, BeijingBioray LaboratoriesZatím nenabírámeRoztroušená skleróza | Neuromyelitida Poruchy optického spektra | Chronická zánětlivá demyelinizační polyradikuloneuropatie | Myasthenia Gravis, generalizovanáČína
-
The Second Hospital of Shandong UniversityAktivní, ne nábor
-
Stephan Grupp MD PhDChildren's Hospital of Philadelphia; Children's Cancer Research Fund; Alliance...NáborVysoce rizikový neuroblastom | Refrakterní neuroblastom | Recidivující neuroblastomSpojené státy
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityDokončenoRefrakterní difúzní velký B-buněčný lymfomČína
-
Zhejiang UniversityCarbiogene Therapeutics Co. Ltd.NáborPokročilý hepatocelulární karcinomČína
-
Nexcella Inc.Immix Biopharma, Inc.NáborAmyloidóza lehkého řetězce (AL).Spojené státy
-
Second Affiliated Hospital, School of Medicine,...NáborRecidivující a refrakterní B-buněčný lymfomČína
-
Second Affiliated Hospital, School of Medicine,...NáborB-buněčný non Hodgkinův lymfomČína
-
Daniel LandiUkončenoGlioblastom | GliosarkomSpojené státy
-
The Second Hospital of Shandong UniversityAktivní, ne náborBezpečnost a účinnost buněčných léků, objektivní míra odpovědi subjektů atd.Čína